Efficacy and Safety of 1470 nm Diode Laser Enucleation of the Prostate in Elderly Benign Prostatic Hyperplasia Patients
Journal of Endourology · 2023
DOI: 10.1089/end.2022.0705 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Endourology, 2023. Verfasst von Dingchang Shao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Transurethral Resection of Prostate, Laser Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objective
The aim of this study was to evaluate efficacy and safety of 1470 nm diode laser enucleation of the prostate (DiLEP) and plasmakinetic resection of the prostate (PKRP) in elderly benign prostatic hyperplasia (BPH) patients with lower urinary tract symptoms.
Methods
A total of 123 elderly patients with BPH were randomized to undergo either 1470 nm DiLEP or PKRP by means of a random number table from September 2020 to April 2022. The perioperative and postoperative data were studied during a 3- and 6-month follow-up.
Results
The patients treated with 1470 nm DiLEP had significantly decreased operation time (74.6 ± 17.0 vs 98.8 ± 18.9 minutes, p < 0.001), hemoglobin loss (1.06 ± 0.49 vs 1.59 ± 0.60 g/dL, p < 0.001), bladder irrigation time (22.1 ± 8.1 vs 33.9 ± 10.0 hours, p < 0.001), catheter duration (3.2 ± 1.3 vs 5.8 ± 1.0 days, p < 0.001), and hospital stay (7.6 ± 1.4 vs 9.6 ± 1.3 days, p < 0.001) compared with the PKRP group. Besides, International Index of Erectile Function-5 score of 1470 nm DiLEP group at postoperative 3- and 6-month follow-up was significantly higher than PKRP group. No differences achieving statistical significance were identified in total prostate-specific antigen, maximum urinary flow rate, International Prostate Symptom Score, quality-of-life score, and the postvoid residual urine volume, transient incontinence, urethral stricture, bladder neck contracture, and retrograde ejaculation at 3- and 6-month follow-up.
Conclusions
1470 nm DiLEP is safer than PKRP, with a smaller effect on sexual function, and it is comparable with the efficacy of PKRP, thus making it more suitable for elderly BPH patients. Clinical Trial Registration number: S2021-463-01.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
- Second Department of Surgery, Shandong Rongjun General Hospital, Jinan, Shandong, China.
- Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Engineering Laboratory of Urinary Organ and Functional Reconstruction of Shandong Province, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
ORCID-Profile: Qiang Fu
Zitieren
APA
Shao, D., Zang, Z., Li, Z., Zhang, H., Sun, D., Diao, T., Wang, Z., Zhang, K., & Fu, Q. (2023). Efficacy and Safety of 1470 nm Diode Laser Enucleation of the Prostate in Elderly Benign Prostatic Hyperplasia Patients. Journal of Endourology. https://doi.org/10.1089/end.2022.0705
Vancouver
Shao D, Zang Z, Li Z, Zhang H, Sun D, Diao T, et al. Efficacy and Safety of 1470 nm Diode Laser Enucleation of the Prostate in Elderly Benign Prostatic Hyperplasia Patients. Journal of Endourology. 2023. doi:10.1089/end.2022.0705
BibTeX
@article{Shao2023,
author = {Shao, Dingchang and Zang, Zhenjie and Li, Ziheng and Zhang, Hui and Sun, Dingqi and Diao, Tongxiang and Wang, Zhenqing and Zhang, Keqin and Fu, Qiang},
title = {Efficacy and Safety of 1470 nm Diode Laser Enucleation of the Prostate in Elderly Benign Prostatic Hyperplasia Patients},
journal = {Journal of Endourology},
year = {2023},
doi = {10.1089/end.2022.0705}
}
EUVIMED